The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer? [electronic resource]
Producer: 20191028Description: 1099-1107 p. digitalISSN:- 1569-8041
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Chemotherapy, Adjuvant -- adverse effects
- Clinical Trials, Phase III as Topic
- Colectomy
- Colonic Neoplasms -- mortality
- Congresses as Topic
- Data Interpretation, Statistical
- Disease-Free Survival
- Humans
- Multicenter Studies as Topic
- Neoplasm Staging
- Neurotoxicity Syndromes -- etiology
- Oxaliplatin -- administration & dosage
- Practice Guidelines as Topic
- Quality of Life
- Randomized Controlled Trials as Topic
- Risk Assessment
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.